(Q43476058)

23 November 2017

title

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. (English)

1 reference

23 November 2017

0 references

1 reference

1 reference

Jean-Michel Pawlotsky

7

1 reference

Françoise Roudot-Thoraval

23 November 2017

9

Sophie Lotersztajn

0 references

2

object named as

Françoise Roudot-Thoraval

1 reference

23 November 2017

Christophe Hézode

1

1 reference

23 November 2017

Son Nguyen

3

1 reference

23 November 2017

Pascale Grenard

4

1 reference

23 November 2017

Boris Julien

5

1 reference

23 November 2017

Elie-Serge Zafrani

6

1 reference

23 November 2017

Daniel Dhumeaux

8

1 reference

23 November 2017

Ariane Mallat

10

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 November 2017

1 reference

23 November 2017

volume

42

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

63-71

1 reference

Estimating future hepatitis C morbidity, mortality, and costs in the United States

23 November 2017

cites work

1 reference

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

7 January 2021

Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.

1 reference

7 January 2021

Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study

1 reference

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

7 January 2021

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

7 January 2021

Fibrogenic impact of high serum glucose in chronic hepatitis C.

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Impact of smoking on histological liver lesions in chronic hepatitis C.

1 reference

7 January 2021

Drug use and drinking among students in 36 countries.

1 reference

7 January 2021

The cannabinoid system and immune modulation

1 reference

7 January 2021

The molecular logic of endocannabinoid signalling

1 reference

7 January 2021

Cannabinoids: potential anticancer agents

1 reference

7 January 2021

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

1 reference

7 January 2021

Hepatic fibrosis: molecular mechanisms and drug targets

1 reference

7 January 2021

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

7 January 2021

Risks of a range of alcohol intake on hepatitis C-related fibrosis

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

1 reference

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

1 reference

7 January 2021

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

1 reference

7 January 2021

Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera

1 reference

7 January 2021

Epidemiology of substance use in adolescence: prevalence, trends and policy implications

1 reference

7 January 2021

Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.

1 reference

7 January 2021

Predictors of cessation of marijuana use: an event history analysis.

1 reference

7 January 2021

The natural history of drug use from adolescence to the mid-thirties in a general population sample

1 reference

7 January 2021

One year follow-up of cannabis dependence among long-term users in Sydney, Australia

1 reference

7 January 2021

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

1 reference

7 January 2021

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20733

1 reference

23 November 2017

1 reference